No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs186301965 |
chr6:126660704-126660705 |
Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs114319412 |
chr6:126660740-126660741 |
Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs536540092 |
chr6:126660771-126660772 |
Active TSS Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs547456926 |
chr6:126660857-126660858 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs192295390 |
chr6:126660945-126660946 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs565681977 |
chr6:126660960-126660961 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs532933688 |
chr6:126660976-126660977 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs184075169 |
chr6:126660979-126660980 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs370852526 |
chr6:126661006-126661007 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs569686788 |
chr6:126661061-126661062 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs537315539 |
chr6:126661069-126661070 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs372284207 |
chr6:126661107-126661108 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs567416019 |
chr6:126661122-126661123 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs375787837 |
chr6:126661131-126661132 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs553429297 |
chr6:126661144-126661145 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs9388486 |
chr6:126661154-126661155 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs544986292 |
chr6:126661208-126661209 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs79157385 |
chr6:126661275-126661276 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs372192318 |
chr6:126661293-126661294 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs367748361 |
chr6:126661295-126661296 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs367746527 |
chr6:126661305-126661306 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs186040085 |
chr6:126661325-126661326 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs528679207 |
chr6:126661341-126661342 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs190907582 |
chr6:126661361-126661362 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs201770676 |
chr6:126661376-126661377 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs142786698 |
chr6:126661442-126661443 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs533023379 |
chr6:126661464-126661465 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs551526114 |
chr6:126661475-126661476 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs569626276 |
chr6:126661478-126661479 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs201673480 |
chr6:126661496-126661497 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs41285260 |
chr6:126661502-126661503 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs567495845 |
chr6:126661512-126661513 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs375635063 |
chr6:126661565-126661566 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541914710 |
chr6:126661583-126661584 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs372798798 |
chr6:126661590-126661591 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs375772295 |
chr6:126661592-126661593 |
Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs34550377 |
chr6:126661609-126661610 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs182439161 |
chr6:126661624-126661625 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs79621298 |
chr6:126661628-126661629 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538698892 |
chr6:126661772-126661773 |
Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs187077217 |
chr6:126661831-126661832 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs9375435 |
chr6:126661858-126661859 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs118102607 |
chr6:126661860-126661861 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs555219719 |
chr6:126661865-126661866 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs191930566 |
chr6:126661912-126661913 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs540935214 |
chr6:126661949-126661950 |
Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs565310597 |
chr6:126662001-126662002 |
Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs532758733 |
chr6:126662003-126662004 |
Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs545087572 |
chr6:126662052-126662053 |
Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs563416347 |
chr6:126662108-126662109 |
Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|